Biogen
BIIB
NASDAQ
IPO1991
about BIIB
Biogen is a biotechnology company specializing in the development of innovative pharmaceutical treatments for various medical conditions, with a focus on neurology and immunology.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $173.49 | $175.08 | $171.27 | $25.3B | 1.79M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$3.18 | 14.73 | 10.09 | 21.99% | 18.40% | 0% |